|
US4078052A
(en)
|
1976-06-30 |
1978-03-07 |
The United States Of America As Represented By The Secretary Of Health, Education And Welfare |
Large unilamellar vesicles (LUV) and method of preparing same
|
|
CH621479A5
(https=)
|
1977-08-05 |
1981-02-13 |
Battelle Memorial Institute |
|
|
CH624011A5
(https=)
|
1977-08-05 |
1981-07-15 |
Battelle Memorial Institute |
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4241046A
(en)
|
1978-11-30 |
1980-12-23 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5270163A
(en)
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
|
US6491916B1
(en)
|
1994-06-01 |
2002-12-10 |
Tolerance Therapeutics, Inc. |
Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
|
|
US5798100A
(en)
|
1994-07-06 |
1998-08-25 |
Immunomedics, Inc. |
Multi-stage cascade boosting vaccine
|
|
US5756122A
(en)
|
1995-06-07 |
1998-05-26 |
Georgetown University |
Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells
|
|
US6242253B1
(en)
|
1997-10-09 |
2001-06-05 |
Regents Of The University Of California |
IkB kinase, subunits thereof, and methods of using same
|
|
CN101041079A
(zh)
|
1999-12-30 |
2007-09-26 |
诺瓦提斯公司 |
用于基因治疗的新的胶体合成载体
|
|
WO2001054719A2
(en)
*
|
2000-01-31 |
2001-08-02 |
Smithkline Beecham Biologicals S.A. |
Vaccine for the prophylactic or therapeutic immunization against hiv
|
|
US20030072794A1
(en)
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
US7427394B2
(en)
|
2000-10-10 |
2008-09-23 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
|
ES2304467T3
(es)
|
2001-07-10 |
2008-10-16 |
North Carolina State University |
Vehiculo de liberacion de nanoparticulas.
|
|
US7550650B2
(en)
|
2001-09-18 |
2009-06-23 |
Synageva Biopharma Corp. |
Production of a transgenic avian by cytoplasmic injection
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
US6740336B2
(en)
|
2002-10-04 |
2004-05-25 |
Mirus Corporation |
Process for generating multilayered particles
|
|
JP2006502228A
(ja)
|
2002-10-07 |
2006-01-19 |
カイロン コーポレイション |
Ｈｉｖワクチン処方物
|
|
DE602004030923D1
(de)
|
2003-09-17 |
2011-02-17 |
Rodos Biotarget Gmbh |
Lipid-arzneimittel-formulierungen zur gezielten pharmakotherapie von myeloiden und lymphoiden immunzellen
|
|
US7592326B2
(en)
|
2004-03-15 |
2009-09-22 |
Karaolis David K R |
Method for stimulating the immune, inflammatory or neuroprotective response
|
|
DK1765860T3
(da)
|
2004-05-19 |
2009-03-09 |
Immunocore Ltd |
Ny-ESO-T.cellereceptor med höj affinitet
|
|
US8663599B1
(en)
|
2004-10-05 |
2014-03-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
US7531624B2
(en)
|
2004-12-03 |
2009-05-12 |
Medtrain Technologies, Llc |
Nuclear targeting sequence
|
|
US7498177B2
(en)
|
2006-04-24 |
2009-03-03 |
Jesus Martinez De La Fuente |
Quantum dots and their uses
|
|
ZA200900379B
(en)
|
2006-07-21 |
2010-08-25 |
Univ California |
Human endogenous retrovirus polypeptide compositions and methods of use thereof
|
|
WO2008109806A2
(en)
|
2007-03-08 |
2008-09-12 |
Massachusetts Institute Of Technology |
Electrostatic coating of particles for drug delivery
|
|
TWI570135B
(zh)
*
|
2007-04-27 |
2017-02-11 |
建南德克公司 |
高效、穩定且非免疫抑制之抗－ｃｄ４抗體
|
|
WO2009017823A2
(en)
|
2007-08-01 |
2009-02-05 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health |
A fold-back diabody diphtheria toxin immunotoxin and methods of use
|
|
US20090136917A1
(en)
|
2007-10-25 |
2009-05-28 |
Szalay Aladar A |
Systems and methods for viral therapy
|
|
EP2130912A1
(en)
|
2008-06-04 |
2009-12-09 |
Institut für Viruskrankeiten und Immunprophylaxe |
Pestivirus replicons providing an RNA-based viral vector system
|
|
WO2010042555A2
(en)
|
2008-10-06 |
2010-04-15 |
The Brigham And Women's Hospital, Inc. |
Particles with multiple functionalized surface domains
|
|
US20110300205A1
(en)
|
2009-07-06 |
2011-12-08 |
Novartis Ag |
Self replicating rna molecules and uses thereof
|
|
US20120192298A1
(en)
|
2009-07-24 |
2012-07-26 |
Sigma Aldrich Co. Llc |
Method for genome editing
|
|
HUE041436T2
(hu)
|
2009-12-10 |
2019-05-28 |
Univ Minnesota |
Tal-effektor-közvetített DNS-módosítás
|
|
US20110229556A1
(en)
|
2010-03-19 |
2011-09-22 |
Massachusetts Institute Of Technology |
Lipid-coated polymer particles for immune stimulation
|
|
US9242857B2
(en)
|
2010-08-14 |
2016-01-26 |
University Of Massachusetts |
Yeast cell wall particles for receptor-targeted nanoparticle delivery
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
US20140030218A1
(en)
|
2011-01-05 |
2014-01-30 |
Imperial Innovations Limited |
Treatment And Screening
|
|
CN102851304A
(zh)
|
2011-06-30 |
2013-01-02 |
复旦大学 |
基于静电包衣的三元非病毒核酸递释系统及其制备方法
|
|
IL286786B
(en)
|
2012-09-14 |
2022-09-01 |
The Us Secretary Department Of Health And Human Services Office Of Technology Transfer National Inst |
T cell receptors that recognize mhc mage–a3 are restricted type ii
|
|
JP6694712B2
(ja)
|
2012-11-01 |
2020-05-20 |
マックス−デルブルック−セントラム フアー モレキュラーレ メデジン |
Ｃｄ２６９（ｂｃｍａ）に対する抗体
|
|
WO2014107566A1
(en)
*
|
2013-01-04 |
2014-07-10 |
Massachusetts Institute Of Technology |
Surface binding of nanoparticle based drug delivery to tissue
|
|
US20160008399A1
(en)
|
2013-01-14 |
2016-01-14 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
|
|
GB201302427D0
(en)
|
2013-02-12 |
2013-03-27 |
Midatech Ltd |
Nanoparticle delivery compositions
|
|
WO2014153114A1
(en)
|
2013-03-14 |
2014-09-25 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to modify cells for therapeutic objectives
|
|
US9828582B2
(en)
|
2013-03-19 |
2017-11-28 |
Duke University |
Compositions and methods for the induction and tuning of gene expression
|
|
EP3783098A1
(en)
|
2013-05-14 |
2021-02-24 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
US10000746B2
(en)
|
2013-05-31 |
2018-06-19 |
Cellectis |
LAGLIDADG homing endonuclease cleaving the T cell receptor alpha gene and uses thereof
|
|
CN105579068A
(zh)
|
2013-09-23 |
2016-05-11 |
伦斯勒理工学院 |
在各种细胞群中纳米颗粒介导的基因传递、基因组编辑和靶向配体的修饰
|
|
EA034103B1
(ru)
|
2013-10-22 |
2019-12-27 |
Транслейт Био, Инк. |
СПОСОБ ЛЕЧЕНИЯ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
|
|
MX389160B
(es)
*
|
2013-10-31 |
2025-03-20 |
Hutchinson Fred Cancer Res |
Células no t efectoras y madre/progenitoras hematopoyéticas modificadas y usos de estas.
|
|
AU2015244039B2
(en)
|
2014-04-07 |
2021-10-21 |
Novartis Ag |
Treatment of cancer using anti-CD19 chimeric antigen receptor
|
|
TWI750110B
(zh)
|
2014-07-21 |
2021-12-21 |
瑞士商諾華公司 |
使用人類化抗-ｂｃｍａ嵌合抗原受體治療癌症
|
|
CN107074970B
(zh)
|
2014-08-04 |
2021-07-30 |
弗雷德哈钦森癌症研究中心 |
特异性针对wt-1的t细胞免疫疗法
|
|
US20160176969A1
(en)
|
2014-11-26 |
2016-06-23 |
Xencor, Inc. |
Heterodimeric antibodies including binding to cd8
|
|
HK1248603A1
(zh)
|
2015-03-10 |
2018-10-19 |
Aduro Biotech, Inc. |
用於活化"干扰素基因的刺激剂"依懒性信号传导的组合物和方法
|
|
WO2016180467A1
(en)
|
2015-05-11 |
2016-11-17 |
Biontech Cell & Gene Therapies Gmbh |
Enhancing the effect of car-engineered t cells by means of nucleic acid vaccination
|
|
US11026969B2
(en)
*
|
2015-12-23 |
2021-06-08 |
Fred Hutchinson Cancer Research Center |
High affinity T cell receptors and uses thereof
|
|
US11136597B2
(en)
|
2016-02-16 |
2021-10-05 |
Yale University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
|
AU2017250295B2
(en)
|
2016-04-14 |
2022-08-25 |
Fred Hutchinson Cancer Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
US10188749B2
(en)
|
2016-04-14 |
2019-01-29 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
EP3458104A1
(en)
|
2016-05-18 |
2019-03-27 |
Modernatx, Inc. |
Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria
|
|
AU2017368320A1
(en)
|
2016-12-02 |
2019-05-02 |
Cartesian Therapeutics, Inc. |
Cancer immuno therapy with highly enriched CD8+ chimeric antigen receptor T cells
|
|
CN111629715A
(zh)
|
2018-01-18 |
2020-09-04 |
弗莱德哈钦森癌症研究中心 |
通过调节细胞活化状态改变体内免疫细胞的炎症状态
|
|
JP2021523110A
(ja)
|
2018-05-01 |
2021-09-02 |
フレッド ハッチンソン キャンサー リサーチ センター |
遺伝子発現のためのナノ粒子及びその使用
|